Better Choice Company Inc. (BTTR)
| Previous close | 5.1400 |
| Open | 5.3800 |
| Bid | 4.8600 x 1300 |
| Ask | 4.9900 x 2200 |
| Day's range | 4.8000 - 5.3800 |
| 52-week range | 4.1500 - 23.2000 |
| Volume | |
| Avg. volume | 281,560 |
| Market cap | 4.423M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -32.2500 |
| Earnings date | 10 May 2024 - 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 88.00 |
GlobeNewswireBetter Choice is Encouraged by the Potential DEA Reclassification of Marijuana
Bona Vida CBD Dog and Cat treats remains a wholly-owned subsidiary of Better ChoiceNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, is encouraged by the potential DEA reclassification of marijuana. Michael Young, Chairman of Better Choice Company, commented, “As the environment for the cannabis industry continues to evolve, we look forward to watching the evolution of regulatory reform. Bona Vid
- GlobeNewswire
Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announced today that it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) dated April 24, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing stand
- GlobeNewswire
Better Choice Company Board of Directors Authorize Stock Repurchase Program
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announces that its Board of Directors has authorized a stock repurchase program under which the Company can repurchase up to $5 million of the currently outstanding shares of the Company’s common stock, until December 31, 2024. Shares may be repurchased in open market or private transactions or pursuant to any trading plan that may b
